MétaCan
Menu
Retour à la cohorte
Enregistrement W4409413705 · doi:10.1001/jamanetworkopen.2025.4748

Population-Wide Screening for Chronic Kidney Disease—A Step Toward Health Equity?

2025· article· en· W4409413705 sur OpenAlexaff
Badal S B Pattar, Sofia B. Ahmed

Notice bibliographique

RevueJAMA Network Open · 2025
Typearticle
Langueen
DomaineMedicine
ThématiqueChronic Kidney Disease and Diabetes
Établissements canadiensLibin Cardiovascular Institute of AlbertaWomen and Children’s Health Research InstituteUniversity of AlbertaUniversity of Calgary
Organismes subventionnairesnon disponible
Mots-clésKidney diseaseEquity (law)Health equityMedicinePopulationInternal medicineEnvironmental healthPolitical sciencePublic healthPathologyLaw

Résumé

récupéré en direct d'OpenAlex

Could widespread screening for chronic kidney disease (CKD) be a step toward health equity?One in seven US adults lives with CKD, but 90% of them are unaware of their diagnosis.1 Moreover, minoritized racial and ethnic groups in the United States, including Alaska Native, American Indian, Black, Latinx, Native Hawaiian, and Pacific Islander individuals, experience a disproportionate burden of advanced CKD and kidney failure, 1,2 underscoring the urgent need to develop processes that not only reduce the overall burden of CKD but also specifically address and mitigate health inequities.3 A report from a National Institute of Diabetes and Digestive and Kidney Diseases workshop recently highlighted the importance of promoting interventions aimed at addressing structural racism and improving access to care. 4 However, to date there has been no consensus on the implementation of CKD screening programs by US (or any other nation's) health systems or governments, although an update is in progress with respect to the US Preventive Services Task Force recommendations on this topic.Persons living with CKD strongly advocate for early detection and screening, 5 and the Kidney Disease: Improving Global Outcomes (KDIGO) 2024 Clinical Practice Guideline for the Evaluation and Management of CKD "strongly support efforts aimed at the early detection and treatment of CKD among people at high risk for CKD." 6 The aging population, coupled with rapidly escalating health care costs of CKD to individuals, health care systems, and society, emphasize the urgent need for CKD prevention.Recent exciting advances in nephrology, such as sodium-glucose cotransporter 2 (SGLT2) inhibition, indicate the potential for significant reductions in CKD progression in those at risk, but could screening for CKD also help eliminate kidney health disparities?Elsewhere in JAMA Network Open, Cusick and colleagues 7 aimed to determine the health outcomes, costs, and cost-effectiveness of population-wide one-time or periodic CKD screening by modeling disease progression among adults in Hispanic, non-Hispanic Black, non-Hispanic White, and additional (non-Hispanic Asian, multiracial, and other) racial and ethnic groups.Using population-based data from the National Health and Nutrition Examination Survey, the authors reported every 5-year screening from 55 to 75 years of age combined with SGLT2 inhibitor use was projected to result in reductions in incidence of kidney failure requiring kidney replacement therapy, gains in discounted and quality-adjusted life-years, and overall reduced health care costs at a population level, while also reducing kidney health disparities across all included racial and ethnic groups.In light of these results, the authors concluded that population-wide screening for CKD was cost-effective, would result in improved kidney health, and may have even greater health benefits to non-Hispanic Black adults if begun at earlier ages.In recent years, federal health institutions such as the US Centers for Disease Control and Prevention and the US Preventive Services Task Force have committed to reaching health equity.The findings of this important study highlight how population screening for CKD could potentially resultin equitable access to early detection of disease and intervention with the goal of achieving optimal kidney health at a population level.CKD is responsible not only for substantial morbidity and increased cardiovascular and all-cause mortality, but also negatively impacts employment and education status.8 Living with CKD, particularly in advanced stages, can result in significant socioeconomic deprivation for individuals and their caregivers by restricting their ability to work and care for family members, which in turn results in poorer health outcomes.As such, addressing the +

Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.

Comment cette classification a été obtenuedéplier

Prédiction machine sur la base complète

Imitation des enseignants

Ni prévalence calibrée, ni vérité terrain. Validation humaine à venir. Le volet Gemma est une étiquette directe du modèle pour chaque travail de la base, lue sur la notice réduite au titre. Le volet Codex est un classifieur appris des 10 348 étiquettes directes de Codex et calibré sur les taux pondérés de l'échantillon; les champs sans appui suffisant ne portent aucun appel Codex. Le mode candidate est l'union des deux volets; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont pas des étiquettes humaines.

score de la tête « metaresearch » (Codex)0,039
score de la tête « metaresearch » (Gemma)0,074
Version: metacan-v3-hybrid-931329e0061cStatut de validation: machine_predicted_unvalidated
Catégories candidatesaucune
Catégories consensuellesaucune
DomaineSignal candidat: aucune · Signal consensuel: aucune
Devis d'étudeSignal candidat: Théorique ou conceptuel · Signal consensuel: aucune
GenreSignal candidat: Commentaire · Signal consensuel: Commentaire
Score de désaccord entre enseignants0,039
Score d'incertitude au seuil0,207

Scores du classifieur distillé par catégorie (deux têtes)

CatégorieCodexGemma
Métarecherche0,0390,074
Méta-épidémiologie (sens strict)0,0010,001
Méta-épidémiologie (sens large)0,0020,001
Bibliométrie0,0020,002
Études des sciences et des technologies0,0020,007
Communication savante0,0080,016
Science ouverte0,0040,013
Intégrité de la recherche0,0120,016
Charge utile insuffisante (le modèle a refusé de juger)0,0210,002

Scores machine (provisoires)

Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.

Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.

Tête enseignante Opus0,046
Tête enseignante GPT0,377
Écart entre enseignants0,331 · la distance entre les deux têtes enseignantes sur ce seul travail
Statut de validationscore_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découle

Classification

machine, non validée

Prédiction automatique; un appel candidat d’une seule source (Gemma direct ou Codex distillé), pas un consensus.

Les modèles n’ont appliqué aucune catégorie : rien dans la taxonomie ne correspondait à ce travail.
Devis d'étudeThéorique ou conceptuel
Domainenon disponible
GenreCommentaire

Le détail, modèle par modèle et score par score, se trouve en fin de page sous « Comment cette classification a été obtenue ».

En bref

Citations0
Publié2025
Routes d'admission1
Résumé présentoui

Explorer davantage

Même revueJAMA Network OpenMême sujetChronic Kidney Disease and DiabetesTravaux en français237 207